论文部分内容阅读
肾脏移植是与透析疗法相并列的治疗慢性肾功能不全病的有效手段之一。Merrill 于1956年在一卵性孪生儿之间进行了肾脏移植,其后 Calne 等在犬的肾脏移植上证实了免疫抑制剂Imuran 的有效性,并在临床上得到广泛应用之后,肾脏移植有了飞跃的进步和普及。在今天,接受过肾脏移植的人们可以很好重新服务于社会。已成为常识了。肾脏移植根据提供者的情况分为活体肾脏移植和死体肾脏移植。在欧美诸国,后者占70～90%。而在日本,死体肾脏移植所占比例却是很小的。现适有 Simmons 等发表了可供
Kidney transplantation is one of the effective measures for the treatment of chronic renal insufficiency, which is tied with dialysis therapy. Merrill had a kidney transplant between an egg twin in 1956. Subsequently Calne et al confirmed the effectiveness of Imuran, an immunosuppressive agent, in kidney transplantation in dogs and have been used clinically for kidney transplantation Leap progress and popularity. Today, people who have undergone kidney transplants can well serve the community again. It has become common sense. Kidney transplantation is divided into living kidney transplant and dead kidney transplant according to the provider’s condition. In Europe and the United States, the latter accounts for 70 ~ 90%. In Japan, the proportion of dead kidney transplants is small. Now available to Simmons et al